Novartis Investigative Site
Quincy, Illinois 62301
0 studies enrolling now · 4 studies all time
What they study most
Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Multiple Myeloma, Non-Hodgkin's Lymphoma
Studies at this site
- Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
- Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early